1st Quarter - Report
ACHAOGEN for ACHAOGEN
Firm
Client
Income
—
Expenses
$45,000
Expense method
A: Lobbying Disclosure Act definitions
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Pharmacy PHA
REVAMP- antibiotic pull incentive DISARM- antibiotic reimbursement Hospital reimbursement ( NTAP and DRG) BARDA funding PAHPA reauthorization as it pertains to antibiotics
| Lobbyist | Covered position, as disclosed |
|---|---|
| STEPHANIE DYSON | — |
Health Issues HCR
Public Health and Bio threat issues as it pertains to antibiotics Hospital reimbursement for antibiotics ( NTAP and DRG) BARDA funding and other private/public funding issues
Foreign entity interest: Mrs.
| Lobbyist | Covered position, as disclosed |
|---|---|
| STEPHANIE DYSON | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.